|
⚲
|
| Keyboard |
| Helen Kim | |
|---|---|
| Firm | |
| Address | c/o Protego Biopharma, Inc 10945 Vista Sorrento Parkway, Suite 150 San Diego, CA 92130 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Protego Biopharma Inc | 021-565675 | Director | 32.9 M of 130.4 M |
||
| Recode Therapeutics Inc | 021-561915 | Director | 29.4 M of 29.4 M |
||
| Aktis Oncology Inc | 021-525672 | Director | 175.0 M of 175.0 M |
||
| Iconovir Bio Inc | 021-484703 | Director | 20.2 M of 20.2 M |
||
| A2 Biotherapeutics Inc | 021-465076 | Director | 71.6 M of 71.6 M |
||
| Protego Biopharma | 021-418860 | Director | 51.0 M of 51.0 M |
||
| Recode Therapeutics Inc | 021-418416 | Director | 259.8 M of 290.0 M |
||
| Iconovir Bio Inc | 021-383121 | Director | 77.0 M of 77.0 M |
||
| A2 Biotherapeutics Inc | 021-378361 | Director | 71.5 M of 71.5 M |
||
| Recode Therapeutics Inc | 021-363315 | Director | 27.5 M of 80.0 M |
||
| Neogene Therapeutics Inc | 021-340287 | Director | 15.0 M of 15.0 M |
||
| Exicure Inc | 021-320477 | Director | 22.0 M of 22.0 M |
||
| Exicure Inc | 021-296273 | Director | 43.1 M of 43.1 M |
||
| Exicure Inc | 021-296275 | Director | 20.8 M of 52.6 M |
||
| Exicure Inc | 021-249941 | Director | 14.8 M | ||
| Sunesis Pharmaceuticals Inc | 021-144882 | Director | 28.5 M of 28.5 M |
||
| NGM Biopharmaceuticals Inc | 021-114428 | Executive Officer | 55.4 M of 55.7 M |
||
| Trinity Biosystems Inc | 021-47911 | Director | 7.5 M of 12.5 M |
||
| Vida Ventures Management Co LLC | |||||
| Vida Ventures III-A LP | 021-395296 | Executive Officer | of 750.0 M |
1.6 M | |
| Vida Ventures III LP | 021-395296 | Executive Officer | of 750.0 M |
750.0 M | |
| Vida Ventures Advisors LLC | |||||
| Vida Ventures II-A LLC | 021-344358 | Executive Officer | 16.0 M of 600.0 M |
10.3 M | |
| Vida Ventures II LLC | 021-344332 | Executive Officer | 536.7 M of 600.0 M |
372.5 M | |